SALL4 and hepatocellular carcinoma: According to a study on hepatocellular carcinoma (HCC) (Zhao et al. 2019), miR-497 directly targets SALL4 and negatively regulates its expression, contributing to the stemness properties and metastatic potential of HCC cells (Zhao et al. 2019).